Skip to main content
. 2015 Dec 1;30(3):1023–1036. doi: 10.1096/fj.14-264358

TABLE 3.

Estimated and projected positions, persons, and PYE for fiscal years 2009–2014a

Metric Estimated
Projected
FY 2009 FY 2010 FY 2011 FY 2012 FY 2013 FY 2014
Total projects 50,885 50,739 50,260 49,912 48,276 47,728
Total direct costs (in billions U.S.$)b 16.06 16.29 16.01 15.76 14.60 15.01
Total positions, n (95% CI) 313,049 313,172 (311,678–314,439) 312,699 (311,063–314,112) 317,984 (316,082–319,667) 314,846 (312,646–316,836) 312,584 (310,342–314,622)
Total persons, n (95% CI) 247,457 247,554 (246,373–248,556) 247,180 (245,887–248,297) 251,358 (249,855–252,688) 248,878 (247,138–250,451) 247,089 (245,317–248,701)
Total PYE, n (95% CI) 121,465 121,742 (121,032–122,343) 121,400 (120,637–122,050) 123,593 (122,722–124,353) 122,730 (121,741–123,612) 121,755 (120,760–122,644)
a

Total number of projects and associated direct costs for FYs 2009–2014 from NIH administrative data. Total positions and PYE projections for FYs 2010–2014 were calculated on the basis of the FY 2009 All Personnel Report estimates of the mean and se of the number of positions and PYE associated with a grant for a given activity code. For activity codes not used in FY 2009, a similar activity code, as determined by NIH staff, was used as a substitute. Total persons estimations for FYs 2010–2014 were calculated according to the person:position ratio in FY 2009, applied to the position totals for FYs 2010–2014.

b

All years adjusted to 2009 dollars by using the Biomedical Research and Development Price Index (BRDPI) (Source: Biomedical Research and Development Price Index, Updated 1-7-2014, see http://officeofbudget.od.nih.gov/gbiPriceIndexes.html). Excludes projects and positions funded through the ARRA.